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Introduction
Retrospective study of patients with chronic tension
headache (CTH) and chronic migraine (CM).
Objective
To compare the efficacy of biofeedback (BFB) compared
to only prophylactic therapy in these primary headaches
[1-4].
Materials and methods
We evaluated a total of 8 patients with CTH and 8
patients with CM. All patients had a history of primary
headache and had never undergone prophylactic ther-
apy. The observation period lasted 90 days. Four CTH
patients and 4 CM patients underwent only prophylactic
therapy (amitriptyline 20 mg daily), the remaining 4
CTH and 4 CM prophylactic therapy and BFB training
sessions. Assessment tools outcome measures were:
- Headache diary to assess days per month with
headache;
- Analgesic consumption and/or triptans;
- Score of the visual analogue pain scale (VAS);
- SEMG parameter for patients who carried out BFB
training.
Results
At the end of the 90 day observational period there was
a significant improvement (reduction in headache days
per month, in VAS score, in analgesic consumption and
in SEMG parameter) in CTH and CM patients that had
undergone both BFB training and prophylactic therapy
when compared to the group of patients treated only
with prophylactic therapy drug.
Discussion and conclusions
The overall data confirmed the efficacy of the BFB train-
ing in the prophylaxis of primary headaches, further
supporting the benefits already possible with the therapy
of only pharmacological prophylaxis (Table 1). The data
also showed a clear dominance of efficacy, especially in
the forms of chronic tension headache (Table 2).
Written informed consent to publication was obtained
from the patient(s).
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Table 1. Overall differences between the two groups






CTH -58% -37% -62%
CTH BFB -75% -67% -86% -54%
CM -53% -34% -60% -50%
CM BFB -61% -43% -75% -63% -54%
Table 2. Differences between CTH and CM in treatment




CTH BFB -75% -67% -86% -54%
CM BFB -61% -43% -75% -54%
Difference CTH BFB
and CM BFB
-14% -24% -11% -50%
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